Similar articles

• Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.

  Maron DJ, Spertus JA, Mancini GB, Hartigan PM, Sedlis SP, Bates ER, Kostuk WJ, Dada M, Berman DS, Shaw LJ, Chaitman BR, Teo KK, O'Rourke RA, Weintraub WS, Boden WE; COURAGE Trial Research Group. Maron DJ, et al. Am J Cardiol. 2009 Oct 15;104(8):1055-62. doi: 10.1016/j.amjcard.2009.05.056. Epub 2009 Aug 28. Am J Cardiol. 2009. PMID: 19801024 Clinical Trial.
• [Medical treatment of patients with stable angina pectoris].

  Castaigne A, Scherrer-Crosbie M, Chazouillères AF, Carville C. Castaigne A, et al. Rev Prat. 1995 Nov 1;45(17):2161-7. Rev Prat. 1995. PMID: 8571041 French.
• Current strategies for the prevention of angina in patients with stable coronary artery disease.

  Bhatt AB, Stone PH. Bhatt AB, et al. Curr Opin Cardiol. 2006 Sep;21(5):492-502. doi: 10.1097/01.hco.0000240588.22086.43. Curr Opin Cardiol. 2006. PMID: 16900014 Review.
• Clinical practice. Chronic stable angina.

  Abrams J. Abrams J. N Engl J Med. 2005 Jun 16;352(24):2524-33. doi: 10.1056/NEJMcp042317. N Engl J Med. 2005. PMID: 15958808 Review. No abstract available.
• Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.

  Deedwania PC, Carbajal EV. Deedwania PC, et al. Am J Med. 2011 Aug;124(8):681-8. doi: 10.1016/j.amjmed.2011.02.036. Am J Med. 2011. PMID: 21787900 Review.